3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors.
about
Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humansNeural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)Psychedelics and Immunomodulation: Novel Approaches and Therapeutic OpportunitiesPharmacological characterization of designer cathinones in vitroA systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.Monoamine reuptake inhibitors in Parkinson's disease.Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4-methylenedioxymethamphetamine (MDMA) and R(-)-MDMA trained mice.3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner.3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.Cardiac effects of MDMA on the metabolic profile determined with 1H-magnetic resonance spectroscopy in the rat.The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.3,4-N-methlenedioxymethamphetamine-induced hypophagia is maintained in 5-HT1B receptor knockout mice, but suppressed by the 5-HT2C receptor antagonist RS102221.Effect of Hallucinogens on Unconditioned Behavior.Cytopathologic features indicative of 5-hydroxytryptamine axon degeneration are observed in rat brain after administration of d- and l-methylenedioxyamphetamine.Structure-activity relationships of MDMA and related compounds: a new class of psychoactive drugs?
P2860
Q21091087-9A7C80AA-25D1-4F4B-85A0-813CEF5D2281Q24619949-4C3A175E-ED7D-447A-B350-D70B71767396Q26799997-42F4EC40-E5D3-4DC3-811D-873EB07A70EEQ28273207-A3A57768-51E2-4C25-B820-4C5F3C93F608Q28484011-5549CBB9-B055-4A23-A55D-8F722498AAE8Q34565712-AF181800-F90C-4761-B8D8-9BB9F84A1F83Q35165280-74E824EF-6328-414E-9178-062E2FA72D53Q37416406-939A820E-55EC-48CB-858D-955CA8AC915DQ38829190-8AFF6899-3653-4DE3-B38B-AC4F3C6676DFQ40624643-026A69D8-AFD9-4870-8BD7-08DB896D7968Q40950605-676D09F0-B6A1-4106-8FC0-52395811819FQ45053664-EF96A8AD-AC7C-4EF4-A3FD-1E2FEAA4C88EQ45236952-387CAA8F-7583-418B-B7CC-926ED3E9AF58Q45279141-009D45F0-D7D0-46AC-B855-D3821E98CDE0Q48481330-CABBD8D5-7B2B-4F70-868A-C7D39987F9C6Q52243743-605244EE-3A19-40CB-B4E1-C6603812E4BB
P2860
3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors.
description
1986 nî lūn-bûn
@nan
1986 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
3,4-Methylenedioxymethamphetam ...... ain 5-HT1 and 5-HT2 receptors.
@ast
3,4-Methylenedioxymethamphetam ...... ain 5-HT1 and 5-HT2 receptors.
@en
3,4-Methylenedioxymethamphetam ...... ain 5-HT1 and 5-HT2 receptors.
@nl
type
label
3,4-Methylenedioxymethamphetam ...... ain 5-HT1 and 5-HT2 receptors.
@ast
3,4-Methylenedioxymethamphetam ...... ain 5-HT1 and 5-HT2 receptors.
@en
3,4-Methylenedioxymethamphetam ...... ain 5-HT1 and 5-HT2 receptors.
@nl
prefLabel
3,4-Methylenedioxymethamphetam ...... ain 5-HT1 and 5-HT2 receptors.
@ast
3,4-Methylenedioxymethamphetam ...... ain 5-HT1 and 5-HT2 receptors.
@en
3,4-Methylenedioxymethamphetam ...... ain 5-HT1 and 5-HT2 receptors.
@nl
P2093
P356
P1433
P1476
3,4-Methylenedioxymethamphetam ...... ain 5-HT1 and 5-HT2 receptors.
@en
P2093
P2888
P304
P356
10.1007/BF00178519
P577
1986-01-01T00:00:00Z
P6179
1015584207